| PD-L1 is upregulated by simultaneous amplification of the PD-L1 and JAK2 genes in non–small cell lung cancer S Ikeda, T Okamoto, S Okano, Y Umemoto, T Tagawa, Y Morodomi, ... Journal of Thoracic Oncology 11 (1), 62-71, 2016 | 186 | 2016 |
| Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer Y Suzuki, T Okamoto, T Fujishita, M Katsura, T Akamine, S Takamori, ... Lung cancer 101, 92-97, 2016 | 142 | 2016 |
| Surgical treatment of neurogenic tumors of the chest M Yamaguchi, I Yoshino, S Fukuyama, A Osoegawa, T Kameyama, ... Annals of thoracic and cardiovascular surgery 10 (3), 148-151, 2004 | 121 | 2004 |
| Significance of spread through air spaces in resected pathological stage I lung adenocarcinoma G Toyokawa, Y Yamada, T Tagawa, Y Kozuma, T Matsubara, N Haratake, ... The Annals of thoracic surgery 105 (6), 1655-1663, 2018 | 119 | 2018 |
| CTLA-4 blockade expands infiltrating T cells and inhibits cancer cell repopulation during the intervals of chemotherapy in murine mesothelioma L Wu, Z Yun, T Tagawa, K Rey-McIntyre, M De Perrot Molecular cancer therapeutics 11 (8), 1809-1819, 2012 | 97 | 2012 |
| Computed tomography features of resected lung adenocarcinomas with spread through air spaces G Toyokawa, Y Yamada, T Tagawa, T Kamitani, Y Yamasaki, ... The Journal of thoracic and cardiovascular surgery 156 (4), 1670-1676. e4, 2018 | 90 | 2018 |
| Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis T Iwata, S Yoshida, K Nagato, T Nakajima, H Suzuki, T Tagawa, ... Surgery today 45, 1263-1270, 2015 | 75 | 2015 |
| Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapy K Takada, S Takamori, Y Yoneshima, K Tanaka, I Okamoto, ... Lung Cancer 145, 18-26, 2020 | 74 | 2020 |
| PD-L1 expression according to the EGFR status in primary lung adenocarcinoma K Takada, G Toyokawa, T Tagawa, K Kohashi, M Shimokawa, T Akamine, ... Lung Cancer 116, 1-6, 2018 | 74 | 2018 |
| Risk factors for developing postthymectomy myasthenia gravis in thymoma patients Y Yamada, S Yoshida, T Iwata, H Suzuki, T Tagawa, T Mizobuchi, ... The Annals of Thoracic Surgery 99 (3), 1013-1019, 2015 | 64 | 2015 |
| Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older E Tsujita, T Utsunomiya, M Ohta, T Tagawa, A Matsuyama, J Okazaki, ... Surgery 147 (5), 696-703, 2010 | 61 | 2010 |
| Clinical impact of probiotics on the efficacy of anti‐PD‐1 monotherapy in patients with nonsmall cell lung cancer: a multicenter retrospective survival analysis study with … K Takada, M Shimokawa, S Takamori, S Shimamatsu, F Hirai, T Tagawa, ... International journal of cancer 149 (2), 473-482, 2021 | 58 | 2021 |
| Clinical impact and risk factors for skeletal muscle loss after complete resection of early non-small cell lung cancer S Takamori, G Toyokawa, T Okamoto, M Shimokawa, F Kinoshita, ... Annals of surgical oncology 25, 1229-1236, 2018 | 56 | 2018 |
| Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date T Akamine, G Toyokawa, T Tagawa, T Seto OncoTargets and therapy, 5093-5101, 2018 | 55 | 2018 |
| Patient-derived xenograft establishment from human malignant pleural mesothelioma L Wu, G Allo, T John, M Li, T Tagawa, I Opitz, M Anraku, Z Yun, M Pintilie, ... Clinical Cancer Research 23 (4), 1060-1067, 2017 | 54 | 2017 |
| Vδ1+ γδ T cells producing CC chemokines may bridge a gap between neutrophils and macrophages in innate immunity during Escherichia coli infection in mice T Tagawa, H Nishimura, T Yajima, H Hara, K Kishihara, G Matsuzaki, ... The Journal of Immunology 173 (8), 5156-5164, 2004 | 53 | 2004 |
| 18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer K Takada, G Toyokawa, Y Yoneshima, K Tanaka, I Okamoto, ... Scientific reports 9 (1), 13362, 2019 | 49 | 2019 |
| Spirometric and radiological evaluation of the remnant lung long after major pulmonary resection: can compensatory phenomena be recognized in clinical cases? T Mizobuchi, H Wada, Y Sakairi, H Suzuki, T Nakajima, T Tagawa, T Iwata, ... Surgery today 44, 1735-1743, 2014 | 49 | 2014 |
| Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors S Takamori, K Takada, M Shimokawa, T Matsubara, T Fujishita, K Ito, ... Lung Cancer 152, 27-33, 2021 | 48 | 2021 |
| Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors K Takada, Y Yoneshima, K Tanaka, I Okamoto, M Shimokawa, S Wakasu, ... Journal of Cancer Research and Clinical Oncology 146, 1217-1225, 2020 | 47 | 2020 |
